Why Is BTAI stock dropping：Further weakness as BioXcel Therapeutics (NASDAQ
Further weakness as BioXcel Therapeutics (NASDAQ
BioXcelTherapeuticshadcashinexcessofallliabilitiesofjustUS$38mwhenitlastreported(June2023).Soifithasn'tremediedthesituationalready,itwillalmostcertainlyhavetoraisemorecapitalsoon.Withthatinmind,youcanunderstan。其他文章還包含有：「BTAIstockplungesto52」、「BioXcelTherapeutics」、「BioXcelTherapeutics(BTAI)MayFindaBottomSoon...」、「WhyIsBioXcelTherapeutics(BTAI)StockDown26%Today?」、「BTAI...
查看更多 離開網站
BTAI stock plunges to 52
https://www.investing.com
Investors have been reacting to a combination of factors, including market volatility and concerns specific to BioXcel's operations and drug ...
BioXcel Therapeutics
https://finance.yahoo.com
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.50.
BioXcel Therapeutics (BTAI) May Find a Bottom Soon ...
https://www.nasdaq.com
When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of ...
Why Is BioXcel Therapeutics (BTAI) Stock Down 26% Today?
https://investorplace.com
BioXcel Therapeutics stock is falling on Friday after the company announced plans for a proposed public offering of BTAI shares.
BTAI stock plunges to 52
https://in.investing.com
BTAI stock plunges to 52-week low of $1.03 amid market challenges. ... market for 5 years over fraudulent scheme, shares of ADAG cos fall.
BioXcel Therapeutics Reports Third Quarter 2024 Financial ...
https://www.stocktitan.net
The company's cost reduction initiatives through workforce reductions have significantly lowered operating expenses, with R&D dropping 74% to ...
Why BioXcel Therapeutics Stock Is Getting Crushed Today
https://www.fool.com
The clinical-stage biotech specialist's share price is down 44.6% as of 11:15 a.m. ET, according to data from S&P Global Market Intelligence.
BTAI Stock Crashes After Agitation Pill Misses Its Mark
https://www.investors.com
BTAI stock plummeted Thursday after BioXcel's Igalmi missed the mark in patients with agitation due to schizophrenia or bipolar disorders.
Why Is BioXcel Therapeutics (BTAI) Stock Down 46% Today?
https://investorplace.com
BioXcel Therapeutics (BTAI) stock is falling on job cuts. This has it reducing its headcount from 190 workers to about 80. That comes as it ...